Sensome’s AI-powered stroke guidewire begins human trials in Australia

The trial adds to Sensome’s multicenter CLOT OUT study

Sensome has begun human trials for its artificial intelligence (AI)-powered stroke guidewire at the Gold Coast University Hospital (GCUH).

The trial will evaluate the safety and efficacy of the Sensome’s Clotild Smart Guidewire system in acute ischemic stroke patients. 

CLOT OUT is Sesome’s first-in-human, multicenter trial earmarked for leading stroke centers across Australia, Belgium, and France. The GCUH trial adds to this initiative. 

Replacing invasive medical procedures, Sensome’s Clotild Smart Guidewire system pairs impedance-based tissue sensors with machine learning algorithms to provide physicians with valuable insights into the clot.

The AI-powered system recently gained FDA approval to aid in treating or diagnosing life-threatening and irreversibly debilitating diseases and conditions.

“Endovascular thrombectomy is no longer just about removing the clot. To get the best result for your patient, you need to get the clot out with complete revascularization the first time,” explains Dr. Hal Rice, director of interventional neuroradiology at GCUH.

Rice added, “The Clotild guidewire is the first device that promises to provide live real-time information during the intervention that can help increase our chances to choose the right interventional approach from the get-go.”

Related Resource

Pharma transactions during the COVID-19 pandemic

How resilient were they?

Whitepaper front coverFree download

According to reports, Sensome aims to enroll up to 100 patients in its CLOT OUT study. Data from preliminary cases will be presented at this year's LINNC conference in Paris and at SLICE Worldwide, an online interactive stroke event.

“Evidence has been mounting over the past few years that factors like the biological clot composition should be considered when choosing the fastest method to remove a clot. The CLOT OUT trial aims to demonstrate that using Clotild in humans is safe and can detect clot composition,” stated Dr. Andrew Cheung, co-coordinating investigator of the study at Liverpool Hospital.

Featured Resources

The definitive guide to warehouse efficiency

Get your free guide to creating efficiencies in the warehouse

Free download

The total economic impact™ of Datto

Cost savings and business benefits of using Datto Integrated Solutions

Download now

Three-step guide to modern customer experience

Support the critical role CX plays in your business

Free download

Ransomware report

The global state of the channel

Download now

Recommended

Medigate and CrowdStrike bolster IoT medical device security
Internet of Things (IoT)

Medigate and CrowdStrike bolster IoT medical device security

10 Sep 2021
Commerce Department creates an artificial intelligence committee
Policy & legislation

Commerce Department creates an artificial intelligence committee

9 Sep 2021
Yext’s Find-a-Doc streamlines finding a doctor with AI
artificial intelligence (AI)

Yext’s Find-a-Doc streamlines finding a doctor with AI

8 Sep 2021
Large US businesses are hackers' ideal ransomware targets
ransomware

Large US businesses are hackers' ideal ransomware targets

7 Sep 2021

Most Popular

Zoom: From pandemic upstart to hybrid work giant
video conferencing

Zoom: From pandemic upstart to hybrid work giant

14 Sep 2021
What are the pros and cons of AI?
machine learning

What are the pros and cons of AI?

8 Sep 2021
Apple patches zero-day flaw abused by infamous NSO exploit
exploits

Apple patches zero-day flaw abused by infamous NSO exploit

14 Sep 2021